Environmental management

The European Medicines Agency (EMA) is committed to help protect the environment for current and future generations. EMA holds a certificate for European Union (EU) eco-management and auditing scheme (EMAS) and runs several initiatives to reduce its environmental footprint.

Updated on 26 January 2026:
'Environmental statement' section

For more information on EMA's governance and reporting, see: 

• Governance and reporting

Certificate of registration

EMA holds an EMAS certificate. This is a voluntary EU standard for environmental management and auditing.

It helps organisations evaluate, report and enhance their environmental performance. 

It also offers a framework to improve environmental efforts, conserve energy and optimise resource use.

EMA received this certificate in January 2025.

For more information, see:

• European Commission: Eco-Management and Audit Scheme (EMAS)

EMAS - certificate of registration

Environmental statement

EMA's environmental statement for 2024 is available. 

The statement provides information on EMA's environmental performance and compliance with applicable legal obligations.

EMA published its first yearly environmental statement in 2025.

Environmental Statement 2024

Environmental statement 2023

Eco-friendly initiatives

EMA has several ongoing initiatives aiming to reduce its environmental footprint. These initiatives include: 

• Making all procurement practices eco-conscious
• Implementing digital workflows to reduce use of paper, such as for printing
• Including energy rating in its procurement of electronic equipment
• Ensuring its office building upholds its current 'excellent' rating as certified by BREEAM (Building Research Establishment Environmental Assessment Methodology)

In addition, EMA leadership provides strategic guidance and promotes continuous improvement in environmental awareness at all levels of the organisation.

For more information, see:

• BREEAM (Building Research Establishment Environmental Assessment Methodology)